Skip to main content
SpringerLink
Log in

When endoscopic therapy or pharmacotherapy fails to control variceal bleeding: what should be done?

Immediate control of bleeding by TIPS?

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Acute variceal bleeding is the major cause of death in patients with chronic liver disease. This justifies the search for a more effective therapy to achieve rapid and definitive hemostasis in every patient. At present, the recommended standard treatment for acute variceal bleeding consists of immediate drug treatment with terlipressin or octreotide together with early endoscopic band ligation or sclerotherapy. In the case of ectopic varices terlipressin and cyanoacrylate embolization (if varices can be reached by endoscope) are in use.

Focus

The treatment is considered to have failed when bleeding continues or significant bleeding recurs within 48 h. This indicates the need for emergency transjugular intrahepatic portosystemic shunting (TIPS) which has been regarded as rescue treatment of choice when standard treatment fails. Although randomized studies against supportive treatment are lacking, the high efficacy and relatively low mortality after TIPS implantation are convincing. It is reasonable that smaller shunts should be preferred (probably 8 mm in diameter) since most patients have an increased risk of liver failure. To increase the effect of the shunt with respect to acute hemostasis it should be combined with transjugular embolization of the varices.

Conclusion

Only strict adherence to the definition of failure of standard treatment and a generous indication to the TIPS implantation before multiorgan failure occurs may decrease the high mortality of acute variceal bleeding.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. Calet P, Desmorat H, Vinel JP, Caucanas JP, Ravaud A, Gerin P, Brouet P, et al (1990) Incidence of large esophageal varices in patients with cirrhosis application to prophylaxis of first bleeding. Gut 31:1298–1302

    PubMed  Google Scholar 

  2. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices (1988) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective Multicenter Study. N Engl J Med 319:983–989

    Google Scholar 

  3. Sarin SK, Lahoti D, Saxena SP, Murthi NS, Makwane UK (1992) Prevalence, classification and natural history of gastric varices: a longterm follow-up study in 568 portal hypertension patients. Hepatology 16:1343–1349

    Google Scholar 

  4. Kim T, Shijo H, Kokawa H, et al (1997) Risk factors for haemorrhage from gastric fundal varices. Hepatology 25:307–312

    CAS  PubMed  Google Scholar 

  5. Ben-Ari Z, McCormick AP, Jain P, Burroughs AK (1995) Spontaneous hemoperitoneum caused by ruptured varices in a patient with noncirrhotic portal hypertension. Eur J Gastroenterol Hepatol 7:87–90

    CAS  PubMed  Google Scholar 

  6. Arnold C, Haag K, Blum HE, Rössle M (1997) Acute hemoperitoneum after large-volume paracentesis. Gastroenterology 113:978–982

    CAS  PubMed  Google Scholar 

  7. Hanisch E, Doertenbach J, Usadel KH (1992) Somatostatin in acute bleeding of oesophageal varices. Pharmacology and rationale for use. Drugs 44 [Suppl 2]:24–35

  8. Eriksson LS, Brundin T, Söderlund C, Wahren J (1987) Hemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol 22:919–925

    CAS  PubMed  Google Scholar 

  9. McCormick PA, Dick R, Siringo S, Wagstaff D, Chesta J, McIntyre N, Burroughs AK (1990) Octeotride reduces acygos blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol 2:489–492

    Google Scholar 

  10. Lin HC, Tsai YT, Lee FT, Lee SD, Hsai LC, Lin WJ, Lo KJ (1992) Hemodynamic evaluation of octreotide in patients with Hepatitis B-related cirrhosis. Gastroenterology 103:229–234

    CAS  PubMed  Google Scholar 

  11. Moller S, Brinch K, Henriksen JH, Becker U (1997) Effect of octreotide on systemic, central, and splanchnic hemodynamics in cirrhosis. J Hepatol 26:1026–1033

    Article  CAS  PubMed  Google Scholar 

  12. Kleber G, Sauerbruch T, Fischer G, Paumgartner G (1988) Somatostatin does not reduce oesophageal variceal pressure in liver cirrhosis. Gut 29:153–156

    CAS  PubMed  Google Scholar 

  13. Nevens F, Van Steenbergen W, Yap SH, Fevery J (1996) Assessment of variceal pressure by continuous non-invasive endoscopic registration: a placebo controlled evaluation of the effect of terlipressin and octreotide. Gut 38:129–134

    CAS  PubMed  Google Scholar 

  14. Avgerinos A, Armoris A, Rekoumis G, Manolakopoulos S, Argirakis G, Raptis S (1995) The effect of somatostatin and octreotide on intravascular esophageal variceal pressure in patients with cirrhosis. J Hepatol 22:379–380

    Article  CAS  PubMed  Google Scholar 

  15. Primignani M, Carpinelli L, Vazzoler MC, Hall de Lima MC, Nolte A, Marcelli R, de Franchis R (1994) Short-term effect of octreotide on intraesophageal variceal pressure: a double-blind placebo controlled study. Eur J Gastroenterol Hepatol 6:1027–1031

    Google Scholar 

  16. Villanueva C, Ortiz J, Minana J, Soriano G, Sabat M, Boadas J, Balanzo J (2000) Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology 121:110–117

    Google Scholar 

  17. Rössle M, Herz R, Gerok W (1981) Effect of somatostatin on portal pressure in cirrhosis. Hepatology 1:541A

    Google Scholar 

  18. Escorsell A, Bandi JC, Andreu V, Moitinho E, Garcia-Pagan JC, Bosch J, Rhodes J (2001) Desensitazion to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology 120:161–169

    CAS  PubMed  Google Scholar 

  19. Corley DA, Cello JP, Adkisson W, Ko W-F, Kerlikowske K (2001) Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology 120:946–954

    CAS  PubMed  Google Scholar 

  20. Gotzsche PC (2002) Somatostatin or octreotide for acute bleeding oesophageal varices (Cochrain Review). In: The Cochrain Library, issue 1:2002. Oxford

    Google Scholar 

  21. Bosch J, Bordas J, Mastai R, et al (1989) Effect of vasopressin on variceal pressure. Gastroenterology 96:541–542

    Google Scholar 

  22. Iwao T, Toyonaga A, Ikegami M, Oho K, Sumino M, Sakaki M, et al (1993) Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone. J Hepatol 19:345–352

    CAS  PubMed  Google Scholar 

  23. Moreau R, Lebrec D (1990) Nitrovasodilators and portal hypertension. J Hepatol 10:263–267

    CAS  PubMed  Google Scholar 

  24. Lin Hc, Tsai YT, Lee FY, et al (1990) Systemic and portal hemodynamic changes following triglycyl-lysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis. J Hepatol 10:370–374

    CAS  PubMed  Google Scholar 

  25. Moller S, Hansen EF, Becker U, Brinch K, Henriksen JH, Bendtsen F (2000) Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver 20:51–59

    Article  CAS  PubMed  Google Scholar 

  26. D'Amico G, Pagliaro L, Bosch J (1995) The treatment of portal hypertension: a meta-analytic review. Hepatology 22:332–354

    CAS  PubMed  Google Scholar 

  27. Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat J-L (1995) Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 346:865–868

    CAS  PubMed  Google Scholar 

  28. Laine LA (2001) Endoscopic treatment of acute or active variceal bleeding. In: De Franchis R (ed) Portal hypertension III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology, and Therapeutic Strategies. Blackwell, Oxford, pp 156–160

  29. Escorsell A, Ruiz del Arbol L, Planas R, et al (2000) Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology 32:471–476

    CAS  PubMed  Google Scholar 

  30. Banares R, Albillos A, Rincon D, et al (2002) Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 35:609–615

    Article  PubMed  Google Scholar 

  31. Lo GH, Lai KH, Cheng JS, et al (1997) Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology 25:1101–1104

    CAS  PubMed  Google Scholar 

  32. Laine L, Cook D (1995) Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: a meta-analysis. Ann Intern Med 123:280–287

    CAS  PubMed  Google Scholar 

  33. Heresbach D, Jacquelinet C, Nouel O, Chaperon J, Bretagne JF, et al (1995) Sclerotherapy versus ligation in hemorrhage caused by rupture of esophageal varices. Direct meta-analysis of randomized trials. Gastroenterol Clin Biol 19:914–920

    CAS  PubMed  Google Scholar 

  34. Soehendra N, Grimm H, Nam V, Berger B (1987) N-Butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy. Endoscopy 19:221–224

    CAS  PubMed  Google Scholar 

  35. Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT (2001) A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 33:1060–1064

    Article  CAS  PubMed  Google Scholar 

  36. Teres J, Cecilia A, Bordas JM, Rimola MB, Bru C, Rodes J (1978) Esophageal tamponade for bleeding varices. Gastroenterology 75:566–569

    CAS  PubMed  Google Scholar 

  37. Norton ID, Andrews JC, Kamath PS (1998) Management of ectopic varices. Hepatology 28:1154–1158

    CAS  PubMed  Google Scholar 

  38. De Franchis R (2001) What have we accomplished? In: De Franchis R (ed) Portal hypertension III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology, and Therapeutic Strategies. Blackwell, Oxford, pp 1–12

  39. Siringo S, McCormick PA, Mistry P, Kaye G, McIntyre N, et al (1991) Prognostic significance of the white nipple sign in variceal bleeding. Gastrointest Endosc 37:51–55

    CAS  PubMed  Google Scholar 

  40. Rössle M, Siegerstetter V, Huber M, Ochs A (1998) The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 18:73–89

    PubMed  Google Scholar 

  41. Haskal ZJ (1999) Improved patency of transjugular intrahepatic portosystemic shunts in humans: creation and revision with PTFE stent-grafts. Radiology 213:759–766

    CAS  PubMed  Google Scholar 

  42. Burroughs AK, Patch D (1999) Transjugular intrahepatic portosystemic shunt. Semin Liver Dis 19:457–473

    CAS  PubMed  Google Scholar 

  43. Haag K, Rössle M, Hauenstein KH, et al (1993) Der transjuguläre intrahepatische portosystemische Stent-Shunt (TIPS) in der Notfallbehandlung der portalen Hypertension. Intensivmedizin 30:479–483

    Google Scholar 

  44. Banares R, Casado M, Rodriguez-Laiz JM, et al (1998) Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol 93:75–79

    Article  CAS  PubMed  Google Scholar 

  45. Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK (1998) "Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 114:981–987

    CAS  PubMed  Google Scholar 

  46. Jalan R, John TG, Redhead DN, et al (1995) A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol 90:1932–1937

    CAS  PubMed  Google Scholar 

  47. LaBerge JM, Somberg KA, Lake JR, et al (1995) Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 108:1143–1151

    CAS  PubMed  Google Scholar 

  48. Le Moine O, Deviere J, Ghysels M, et al (1994) Transjugular intrahepatic portosystemic stent shunt as a rescue treatment after sclerotherapy failure in variceal bleeding. Scand J Gastroenterol Suppl 207:23–28

    PubMed  Google Scholar 

  49. McCormick PA, Dick R, Panagou EB, et al (1994) Emergency transjugular intrahepatic portasystemic stent-shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg 81:1324–1327

    CAS  PubMed  Google Scholar 

  50. Sanyal AJ, Freedman AM, Luketic VA, et al (1996) Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 111:138–146

    CAS  PubMed  Google Scholar 

  51. Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M (1998) Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension. Comparison of emergency and elective interventions. Dig Dis Sci 43:2463–2469

    Google Scholar 

  52. Sarfeh IJ, Rypins EB, Conroy RM, Mason JR (1983) Portacaval H-graft: relationship of shunt diameter, portal flow patterns and hepatic encephalopathy. Ann Surg 197:422–426

    CAS  PubMed  Google Scholar 

  53. Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, Rodes J (1995) Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 346:1056–1059

    CAS  PubMed  Google Scholar 

  54. Villanueva C, Balanzo J, Novella MT, Soriano G, Sainz S, Torras X, Cusso X, Guarner C, Vilardell F (1996) Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 334:1624–1629

    Google Scholar 

  55. Rössle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K (2001) How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with a transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 96:3379–3383

    Article  PubMed  Google Scholar 

  56. Huonker M, Schumacher YO, Ochs A, Sorichter S, Keul J, Rossle M (1999) Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 44:743–748

    CAS  PubMed  Google Scholar 

  57. Jalan R, Elton RA, Redhead DN, Finlayson NDC, Hayes PC (1995) Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 23:123–128

    Article  CAS  PubMed  Google Scholar 

  58. Chalasani N, Clark WS, Martin LG, Kamean J, Khan MA, Patel NH, Boyer TD (2000) Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 118:138–144

    CAS  PubMed  Google Scholar 

  59. Brensing KA, Raab P, Textor J, Görich J, Schiedermaier P, Strunk H, et al (2002) Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis. Eur J Gastroenterol Hepatol 14:723–731

    Article  PubMed  Google Scholar 

  60. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Ter Borg PCJ (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:865–871

    Google Scholar 

  61. Rubin RA, Haskal ZJ, O'Brian CB, Cope C, Brass CA (1995) Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores. Am J Gastroenterol 90:556–563

    CAS  PubMed  Google Scholar 

  62. Patch D, Nikolopoulo V, McCormick A, Dick R, Armonis A, Wannamethee G, Burroughs AK (1998) Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatology 28:454–460

    Article  CAS  Google Scholar 

  63. Shellman R, Fulkerson W, De Long F, Piantadosi C (1988) Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit. Crit Care Med 16:671–678

    CAS  PubMed  Google Scholar 

  64. Hendersen JM, Nagle A, Curtas S, Geisinger M, Barnes D (2000) Surgical shunts and TIPS for variceal decompression in the 1990s. Surgery 128:540–547

    Article  CAS  PubMed  Google Scholar 

  65. Helton WS, Maves R, Wicks K, Johansen K (2001) Transjugular intrahepatic portosystemic shunt vs surgical shunt in good-risk cirrhotic patients. Arch Surg 136:17–20

    CAS  PubMed  Google Scholar 

  66. Rosemurgy AS, Goode SE, Zwiebel BR, Black TJ, Brady PG (1996) A prospective trial of transjugular intrahepatic portosystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg 224:378–386

    Article  CAS  PubMed  Google Scholar 

  67. Wolff M, Kalff JC, Hirner A (1999) Portosystemische Shuntchirurgie und transjugulärer intrahepatischer Stent (TIPS) in Deutschland. Chirurg 70:447–452

    Article  CAS  PubMed  Google Scholar 

  68. Barange K, Peron J-M, Imani K, et al (1999) Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 30:1139–1143

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Praxiszentrum, Bertoldstrasse 48, 79098, Freiburg, Germany

    Martin Rössle

Authors
  1. Martin Rössle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Rössle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rössle, M. When endoscopic therapy or pharmacotherapy fails to control variceal bleeding: what should be done? . Langenbecks Arch Surg 388, 155–162 (2003). https://doi.org/10.1007/s00423-003-0372-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-003-0372-8

Keywords

Search

Navigation